FDA Commissioner Marty Makary vows to launch review of abortion drug mifepristone

The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be subject to scrutiny following a new report showing a much larger share of women experience adverse effects after taking it than previously believed. 

Read More

The Christian Post | RSS

Generated by Feedzy